ArticleFrontiers in immunology2023

MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.

Aurora Zanghì et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.